Wordt geladen...
No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients
The discovery that BRAF is a driver oncogene in cancer, and complementary improvements in our understanding of the immune system have resulted in new targeted and immune‐therapies for metastatic melanoma. Targeted therapies achieve impressive clinical results in carefully selected patients but the d...
Bewaard in:
| Gepubliceerd in: | Mol Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528622/ https://ncbi.nlm.nih.gov/pubmed/25178978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.027 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|